With the Susan G. Komen decline in revenue and Race for the Cure participation, including a 32 percent drop in revenue from its signature 3-Day Race for the Cure, its cut of seven of its 14 3-Day races next year, Nancy Brinker's 64% increase in compensation to over $600,000, its public relations debacle regarding funding eligibility criteria for Planned Parenthood, its virtual total turnover of executives (with large donor-paid severances), as well as executive turnover among its 120 affiliates, massive turnover at the board level, Brinker's protracted stay as CEO even after promising to leave, Susan G. Komen for the Cure in Dallas, Texas announced today that its 10-member Board of Directors has appointed Judith A. Salerno, M.D., M.S., as the new CEO. Salerno is executive director and chief operating officer of the Institute of Medicine of the National Academy of Sciences in Washington, D.C.
Nonprofit Imperative gathers its information principally from public documents...some of which are directly quoted. Virtually all cited are in some phase of criminal proceedings; some have not been charged, however. Cites in various media: Featured in print, broadcast, and online media outlets, including: Vermont Public Radio, Miami Herald, National Public Radio, Huffington Post, The Sun News, Atlanta Journal Constitution, Wall Street Journal (Profile, News and Photos), FOX2, ABC Spotlight on the News, WWJ Radio, Ethics World, Aspen Philanthropy Newsletter, Harvard Business Review, Current Affairs, The Chronicle of Philanthropy, St. Petersburg Times, B, USA Today Topics, Newsweek.com, Responsive Philanthropy Magazine, New York Times...and many more Nonprofits: On the Brink (2006) Silence: The Impending Threat to the Charitable Sector (2011)